Relief Cardiovascular Announces $12M Series A Financing to Advance First-in-Human Study of the Relief System
/
DateJan 08 2025
IRVINE, Calif., Jan. 8, 2025 /PRNewswire/ — Relief Cardiovascular, an inQB8 Medical Technologies portfolio company pioneering innovative solutions for the management of heart failure, today... Read More →